CAS: 594839-88-0 - Tafamidis
Formula:C14H7Cl2NO3
InChI:InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)
InChI key:InChIKey=TXEIIPDJKFWEEC-UHFFFAOYSA-N
SMILES:O=C(O)C=1C=CC=2N=C(OC2C1)C=3C=C(Cl)C=C(Cl)C3
Ref: 4Z-T-302001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Tafamidis-d3
CAS:594839-88-0
Formula:
C14H4D3Cl2NO3
Color and Shape:
White To Off-White Solid
Molecular weight:
311.13
Ref: 4Z-T-302003
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Tafamidis
CAS:594839-88-0
Tafamidis stabilizes TTR, preventing amyloid buildup; binds with negative cooperativity (Kd1: 3 nM, Kd2: 278 …
Formula:
C14H7Cl2NO3
Purity:
99.34%
Color and Shape:
Solid
Molecular weight:
308.12
Ref: TM-T4565
| 5mg | 56.00 € | ||
| 10mg | 92.00 € | ||
| 25mg | 152.00 € | ||
| 50mg | 222.00 € | ||
| 100mg | 345.00 € | ||
| 1mL*10mM (DMSO) | 62.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
CAS:594839-88-0
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid (XZP) is a diagnostic agent used in the diagnosis of certain diseases. …
Formula:
C14H7Cl2NO3
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
308.12 g/mol
Ref: 3D-FD27988
| 10mg | 194.00 € | ||
| 25mg | 310.00 € | ||
| 50mg | 436.00 € | ||
| 100mg | 723.00 € | ||
| 250mg | 985.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
CAS:594839-88-0
Formula:
C14H7Cl2NO3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
308.1163
Ref: IN-DA00ECES
| 10mg | Discontinued | Request information |
